Ocaliva (obeticholic acid): Drug Safety Communication - Increased Risk of Serious Liver Injury
Date of publication: 21-09-2017
Reports of Ocaliva being incorrectly dosed in some patients with moderate to severe decreases in liver function. Some patients received a higher frequency of dosing than is recommended in the drug label. Źródło: https://www.fda.gov
